Literature DB >> 31589244

Avoiding Harm From Hyperbilirubinemia Screening-Reply.

Scott D Grosse1, Lisa A Prosser2,3, Jeffrey R Botkin4.   

Abstract

Entities:  

Year:  2019        PMID: 31589244      PMCID: PMC7203610          DOI: 10.1001/jamapediatrics.2019.3762

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


× No keyword cloud information.
  5 in total

Review 1.  Screening for Neonatal Hyperbilirubinemia-First Do No Harm?

Authors:  Scott D Grosse; Lisa A Prosser; Jeffrey R Botkin
Journal:  JAMA Pediatr       Date:  2019-07-01       Impact factor: 16.193

2.  Childhood Seizures After Phototherapy.

Authors:  Thomas B Newman; Yvonne W Wu; Michael W Kuzniewicz; Barbara A Grimes; Charles E McCulloch
Journal:  Pediatrics       Date:  2018-10       Impact factor: 7.124

3.  Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review.

Authors:  Aaron J Goldenberg; Anne Marie Comeau; Scott D Grosse; Susan Tanksley; Lisa A Prosser; Jelili Ojodu; Jeffrey R Botkin; Alex R Kemper; Nancy S Green
Journal:  Matern Child Health J       Date:  2016-03

4.  Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.

Authors:  Ned Calonge; Nancy S Green; Piero Rinaldo; Michele Lloyd-Puryear; Denise Dougherty; Coleen Boyle; Michael Watson; Tracy Trotter; Sharon F Terry; R Rodney Howell
Journal:  Genet Med       Date:  2010-03       Impact factor: 8.822

5.  Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.

Authors:  Alex R Kemper; Nancy S Green; Ned Calonge; Wendy K K Lam; Anne M Comeau; Aaron J Goldenberg; Jelili Ojodu; Lisa A Prosser; Susan Tanksley; Joseph A Bocchini
Journal:  Genet Med       Date:  2013-08-01       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.